D. Medical Rises to Week High as Canada Approves Health Solution

D. Medical Industries Ltd. climbed to the highest level in a week after the developer of drug-delivery devices said a unit received a license from Health Canada to sell its Spring Universal Infusion sets in that country.

The shares increased 4 percent to 16.46 shekels, the highest intraday level since May 8, as of 11:32 a.m. in Tel Aviv. That gives the Ramat Gan, Israel-based company a market value of 128 million shekels ($36 million).

To contact the reporter on this story: Ronit Goodman in Tel Aviv at rgoodman9@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.